Deciphering the roles of phosphoinositide lipids in phagolysosome biogenesis

ABSTRACT

Professional phagocytes engulf microbial invaders into plasma membrane-derived phagosomes. These mature into microbicidal phagolysosomes, leading to killing of the ingested microbe. Phagosome maturation involves sequential fusion of the phagosome with early endosomes, late endosomes, and the main degradative compartments in cells, lysosomes. Some bacterial pathogens manipulate the phosphoinositide (PIP) composition of phagosome membranes and are not delivered to phagolysosomes, pointing at a role of PIPs in phagosome maturation. This hypothesis is supported by comprehensive microscopic studies. Recently, cell-free reconstitution of fusion between phagosomes and endo(lyso)somes identified phosphatidylinositol 4-phosphate [PI(4)P] and phosphatidylinositol 3-phosphate [PI(3)P] as key regulators of phagolysosome biogenesis. Here, we describe the emerging roles of PIPs in phagosome maturation and we present tools to study PIP involvement in phagosome trafficking using intact cells or purified compartments.

Phagocytosis and phagosome maturation

Phagosomes are compartments which are formed when phagocytic cells ingest microorganisms and which subsequently mature into microbicidal phagolysosomes, leading to oxidative and nonoxidative killing of enclosed microbes.^1,2,3 During maturation, phagosomes sequentially fuse with and acquire the characteristics of early endosomes, late endosomes, and lysosomes.³ The interactions between the various phagocytic and endocytic compartments are vectorially ordered in that early phagosomes do not directly fuse with lysosomes.^2,4 As with other membranes of the secretory and endocytic pathway, phagosome-endo(lyso)some fusion is governed by compartment-specific Rab (Ras-like protein from rat brain) and SNARE (soluble NSF attachment protein receptor) proteins,^1,3 some of which have been identified.⁵ Rab5 and Rab7 are the best-characterized regulator GTPases of the endocytic and phagocytic pathways.^5,6 Similar to maturing endosomes, phagosomes first recruit Rab5 which then is gradually replaced by Rab7. This Rab5-to-Rab7 conversion is presumably regulated by SAND1/Mon1-Ccz1 (SAND1, SAND endocytosis protein family 1; Mon1, monensin sensitivity 1; Ccz1, calcium caffeine zinc sensitivity 1), a Rab5 effector complex which links inactivation and release of Rab5 to Rab7 recruitment and activation.^7,8,9 Rab5 promotes fusion of the phagosome with early endosomes ¹⁰ and Rab7 with late endosomes/lysosomes.^2,11 Hence, Rab5-to-Rab7 conversion on phagosomes drives transition of early phagosomes into late phagosomes/phagolysosomes.

As they mature, phagosomes are acidified by the proton-pumping vacuolar ATPase (vATPase), resulting in a luminal pH of 4.5–5.0 in phagolysosomes.^12,13 The acidic milieu within phagolysosomes activates lysosomal hydrolases and regulates degradation of the phagosome's contents.¹⁴ In addition to acid hydrolases and low pH, the microbicidal arsenal of phagolysosomes includes antimicrobial peptides (e.g., defensins), reactive oxygen (ROS) and nitrogen species (RNS). ROS and RNS are generated by a NADPH-oxidase complex and a NO-synthase, respectively.¹

As with the endocytic pathway, membrane constituents to be degraded within or recycled from phagosomes are presumably incorporated into vesicles that either enter the phagosome lumen or bud from the phagosome.⁵ Intriguingly, the machineries that drive inward (i.e., ESCRT complex, endosomal sorting complex required for transport) or outward budding (i.e., SNXs, sorting nexins) of the phagosome membrane, are required for phagolysosome formation.^15,16 Phagolysosome formation, moreover, is regulated by the cytoskeleton,^11,17,18 calcium currents,^1,5,19 and lipids, especially phosphoinositides (PIPs).^20,21

PIPs

“PIPs” is a summary expression for 7 different, mono-, bis-, or tris-phosphorylated derivatives of the glycerophospholipid phosphatidylinositol (PI) that are generated by phosphorylation of the D3-, D4-, and/or D5-hydroxyl groups of the inositol moiety of PI.²² Many of the PIP isomers can be interconverted by PIP kinases and PIP phosphatases^22,23 and subcellular distribution and substrate specificity of these enzymes causes accumulation of PIPs in defined subcellular compartments.²⁴ PI(3)P is enriched in early endosomes/phagosomes, PI(4)P in the Golgi complex, secretory vesicles, and the plasma membrane, PI(3,5)P₂ in late endosomes/lysosomes, and PI(4,5)P₂ and PI(3,4,5)P₃ in the plasma membrane.^22,25,26 Notably, each of these lipids can be present in small amounts in other membrane compartments.²² Though PIPs are rare lipids, they regulate many cellular processes, such as membrane remodeling, transport, and fusion in the biosynthetic/secretory and endocytic pathway.

Most often, PIPs exert their functions by recruiting effector proteins to specific subcellular compartments and/or to regulate the activity of these factors.²⁷ PIP effector proteins usually contain conserved PIP-binding modules such as ANTH (AP180 N-terminal homology), C2 (conserved region-2 of protein kinase C), ENTH (epsin N-terminal homology), FERM (Protein 4.1, Ezrin, Radixin, Moesin), FYVE (Fab1, YOTB, Vac1, EEA1), Golph3 (Golgi phosphoprotein 3), GRAM (glycosyltransferases, Rab-like GTPase activators and myotubularins), PDZ (postsynaptic density 95, disk large, zonula occludens), PH (pleckstrin homology), PHD (plant homeodomain), PTB (phosphotyrosine binding), or PX domains (phox homology).^27,28 Some of these PIP-binding proteins domains bind to multiple PIPs, some to one PIP isomer exclusively. Often, PIP effectors require additional determinants to bind to membranes or to influence a cellular process. Examples for such additional factors are other lipids (e.g., PIPs), small GTPases and/or presence of certain membrane curvature. These additional affinities of PIP effectors are either encoded in the PIP-binding domain itself or they are mediated by a distinct portion of the effector protein.²⁹ Hence, PIPs function in a process commonly referred to as “coincidence detection.”²⁹

Detection of PIPs in biological samples

The major challenge of analyzing the PIP content of a biological sample is to distinguish between the various PIP isomers. This can be done by either specific PIP-binding proteins or by separating (deacylated) PIPs according to physical properties (i.e. mass, charge, and/or hydrophobicity) using TLC (thin layer chromatography), HPLC (high performance liquid chromatography), or mass spectrometry.²⁷ All of these approaches are suitable to analyze the composition of lipid extracts^30,31,32 and can be combined with cell fractionation techniques to determine the subcellular localization of the various PIPs.³³ However, the subcellular distribution of PIPs has largely been analyzed using PIP-binding proteins which can be applied to microscopically detect PIPs in (intact) cells or tissue sections.²⁷ The above approaches to analyze PIPs are detailed below:

Detection of PIPs by PIP-binding proteins

Upon expression of epitope tag PIP-binding domain fusion proteins in cells, the subcellular localization of the PIP probe and, thus, of the corresponding lipid can be visualized by immunoelectron or immunofluorescence microscopy. Expression of PIP-binding domains fused to fluorescent proteins (e.g., GFP, green fluorescent protein) even allows for detection of PIPs in live cells. Alternatively, purified PIP-binding domains or PIP-specific antibodies can be used to stain free PIPs in untransfected cells after fixation and permeabilization.^27,32,34 As discussed above, some PIP-binding modules bind to more than one PIP isomer and require additional cues for membrane localization. The experimentally perfect PIP sensor is specific for a single PIP and should not depend on additional membrane receptors.³⁵ To reliably assign a PIP to a certain subcellular compartment, it is moreover advisable to use independent sensors against the corresponding lipid.

Aside the use of PIP-binding domains, other methods have been developed to analyze the PIP content of purified compartments. These include the detection of radiolabeled (deacylated) PIPs by TLC or HPLC, or of unlabeled PIPs by HPLC or mass spectrometry:

Detection of radiolabeled (deacylated) PIPs by TLC or HPLC

Here, membrane preparations are incubated in the presence of ³²P labeled ATP which is biosynthetically incorporated into PIPs by phosphoinositide kinases (PIKs). Lipids are extracted, separated by TLC or reverse phase HPLC, and radioactive PIPs are quantified.²⁷ Alternatively, PIPs can be deacylated and separated by anion exchange HPLC. PIP isomers are identified by co-migration (TLC) or co-elution (HPLC) with (deacylated) PIP standards. The latter can be used to quantify the amount of a defined PIP in a lipid mixture. These approaches, though highly sensitive, visualize only the turnover of PIPs and exclude dormant PIP pools, such as the pool of PI(3,4,5)P₃ in the plasma membrane of resting cells.^36,37

Detection of non-radioactive PIPs by HPLC and/or mass spectrometry

Non-radioactive methods for the biochemical detection of free and complexed PIPs in a sample rely on HPLC³³ and/or mass spectrometry.³⁸ Detection of unlabeled PIPs by HPLC is less sensitive than by radioactivity-based methods.²⁷ Mass spectrometry detection of unlabeled PIPs is rather sensitive, yet fails to distinguish between the mono- or the bis-phosphorylated PIP species.³⁹ Recently, a combinatorial approach of HPLC separation and subsequent mass spectrometry analysis of deacylated PIPs has been developed, allowing for detection and quantification of all PIP isomers in a complex lipid mixture.³⁶

PIPs in phagosome maturation

Although there is a detailed picture of which PIPs are required for phagosome formation at the plasma membrane,^21,40 little is known about the PIPs involved in subsequent phagosome maturation. Tables 1 and 2 summarize the current knowledge on the roles of PIPs and PIP-modifying enzymes in phagosome maturation.

Table 1.

PIPs and their roles in phagosome maturation.

PIP	Localization	Role(s) in phagosome maturation
PI(3)P	EP [M]32,61,108 LP [M] 53,54	1. Regulates Rab5-to-Rab7 conversion on phagosomes60 and, hence, early-to-late phagosome transition, presumably by recruiting the Rab5 effector SAND1-Mon1/Ccz1.7,8,9 2. Drives actin polymerization on early phagosomes, by displacing from phagosomes Inpp5B, a PIP phosphatase that dephosphorylates PI(4,5)P2 and PI(3,4,5)P3, PIPs required for phagosomal F-actin assembly.57 Actin polymerization around phagosomes is required for the formation of acidic late phagosomes.57 3. Contributes to recruitment of EEA1 and Rabensyn-5, PI(3)P effectors required for homotypic fusion between early endosomes 109,110,111 and, presumably, between early phagosomes and early endosomes.3 4. Contributes to recruitment of Hrs (ESCRT-0) and, hence, contributes to sorting of ubiquitylated cargo proteins into intraendosomal and, presumably, intraphagosomal vesicles.15 Hrs is required for phagolysosome formation.15 5. Contributes to recruitment of sorting nexins and, thus, presumably, promotes formation of recycling intermediates that bud off from phagosomes.16 Sorting nexins are required for phagolysosome formation.16 6. Recruits and/or activates the NADPH oxidase complex in cooperation with PI(3,4)P2,80 supporting the oxidative burst as a defense mechanism. 7. Contributes to recruitment of FYCO-1, a PI(3)P effector which binds to Rab7(GTP) and LC3 100 and which has been implicated in phagolysosome formation during LC3-associated phagocytosis.81 8. Recruits PI3,5K PikFYVE and serves as a substrate for the formation of PI(3,5)P2.77 PI(3,5)P2 is presumably required for phagolysosome formation.70 9. Is required for early phagosome-early endosome fusion and late phagosome-lysosome fusion.4
PI(4)P	EP [M] 112, PL [HPLC; purified compartments] 104	1. Serves as a substrate for the formation of PI(4,5)P2 on phagolysosomes.104 PI(4,5)P2 is required for actin polymerization around phagolyosomes.104 Actin polymerization around phagolysosomes facilitates phagosome-lysosome fusion.18 2. Is required for phagosome-lysosome fusion.4
PI(5)P	n.d.	n.d.
PI(3,4)P2	EP [M]80	1. Recruits and/or activates the NADPH oxidase complex in cooperation with PI(3)P supporting the oxidative burst as a defense mechanism.80
PI(3,5)P2	n.d.	n.d.
PI(4,5)P2	EP [M]57, PL [M, HPLC; purified compartments]104	1. Promotes actin polymerization on early phagosomes57 and phagolysosomes.17,104 Actin polymerization around phagosomes is required for phagolysosome formation.18,57
PI(3,4,5)P3	EP [M]57, PL [HPLC]104	1. Promotes actin polymerization on early phagosomes.57 Actin polymerization around phagosomes is required for phagolysosome formation.18,57 2. Serves as a substrate for the formation of PI(3)P on early endosomes113 and, presumably, early phagosomes. The formed PI(3)P is required for early phagosome-early endosome fusion.4

n.d.: not determined

M: microscopic detection via lipid-binding proteins

HPLC: detection via high performance liquid chromatography

NP: nascent phagosomes

EP: early phagosomes

LP: late phagosomes

PL: phagolysosomes

Table 2.

PIP-modifying enzymes with a role in phagosome maturation.

PIP- modifying enzyme	Substrate(s)	Product(s)	Localization	Role(s) in phagosome maturation
Vps34 (kinase)	PI	PI(3)P	EP [M, IF of overexpressed Vps34] 61	Generates PI(3)P on early phagosomes and phagolysosomes and is required phagolysosome formation.4,61,62
**MTM1 (phosphatase)	PI(3)P	PI	n.d.	*Dephosphorylates PI(3)P generated in early phagosome membranes and is required for phagolysosome formation.53
**PIKI-I (kinase)	PI	PI(3)P	*EP [M/GFP]53	*Generates PI(3)P in early phagosome membranes and is required for recruitment of Rab2, Rab5, and Rab7 to phagosomes, and for phagolysosome formation.53
PI4KIIα (kinase)	PI	PI(4)P	EP [M/GFP]57; EP, LP, PL [IB] 4	Generates PI(4)P in phagolysosome membranes and is required for phagosome-lysosome fusion.4
PikFYVE (kinase)	PI, PI(3)P	PI(5)P, PI(3,5)P2	n.d.	Is required for late phagosome/phagolysosome formation.70
SHIP-1 (phosphatase)	PI(3,4,5)P3	PI(3,4)P2	NP/EP [M/YFP] 80	Is required for ROS production in phagosomes and affects phagosome maturation.80
Inpp5e (phosphatase)	PI(3,4,5)P3	PI(3,4)P2	n.d.	Promotes recruitment of Rab20 to early phagosomes. Rab20 activates the Rab5 GEF Rabex5 and, hence, Rab5. Active Rab5 stimulates Vps34-dependent accumulation of PI(3)P on early phagosomes114 which is required for phagosome maturation.3
Inpp5B (phosphatase)	PI(3,4,5)P3, PI(4,5)P2	PI(3,4)P2, PI(4)P	EP [M/GFP]57	Degrades PI(3,4,5)P3 and PI(4,5)P2 in early phagosome membranes and inhibits actin polymerization around early phagosomes.57 Actin polymerization around early phagosomes is correlated with the formation of acidic late phagosomes.57
p110α (kinase)	PI(4,5)P2	PI(3,4,5)P3	PL [IB]64	Generates PI(3,4,5)P3 in late phagosomes/phagolysosomes and is required for phagolysosome formation.64
pTEN (phosphatase)	PI(3)P	PI	n.d.	Removes PI(3)P from early phagosomes.77 Impact on phagolysosome formation remains to be elucidated.
OCRL (phosphatase)	PI(3,4,5)P3, PI(4,5)P2	PI(3,4)P2, PI(4)P	NP/EP [M/GFP] 78	Removes PI(3,4,5)P3 and PI(4,5)P2 from early phagosomes.78 Impact on phagolysosome formation remains to be elucidated.

^*Apoptotic body-containing phagosomes in C. elegans

n.d: not determined

M/G(Y)FP: microscopic detection of the enzyme fused to G(Y)FP

NP: nascent phagosomes

EP: early phagosomes

LP: late phagosomes

PL: phagolysosomes

PIPs in phagosome maturation – lessons learned from intracellular pathogens

Selection pressure from the host can lead to the evolution of pathogen structures, molecules, and strategies which protect the pathogen from being delivered to and killed within phagolysosomes. Such pathogens (i) disrupt the phagosome membrane and escape into the cytosol (e.g., Listeria monocytogenes), (ii) block phagosome maturation at a pre-phagolysosome stage (e.g., Salmonella enterica, Mycobacterium tuberculosis), (iii) they transform the phagosomes in which they reside, into non-endocytic compartments (e.g., Legionella pneumophila), or (iv) are adapted to the acidic and degradative milieu within phagolysosomes (e.g., Coxiella burnetii).^1,41 Some of these “intracellular” pathogens manipulate the PIP metabolism in their host cells, resulting in altered maturation of pathogen-containing phagosomes.⁴² Pathogen strategies impacting on or exploiting host cell PIP metabolism include (i) production of PIP-binding effector proteins that use PIPs as a membrane anchor, (ii) introduction of lipid and protein factors that activate, inactivate, or recruit host cell PIP-metabolizing enzymes, or of (iii) PIP-metabolizing enzymes that directly modify host cell PIPs.⁴¹ For excellent reviews on PIP-targeting effector proteins of bacterial pathogens, we refer the reader to references 41 and 42. Here, we confine our presentation to pathogenic bacteria which block phagolysosome formation by secreting phosphatases which directly dephosphorylate PIPs:

S. enterica

Salmonellae secrete effector proteins into host cells using a dedicated bacterial type III secretion system. One of the effector proteins translocated in this way is SopB (Salmonella outer protein B) which dephosphorylates PI(3,5)P₂, PI(3,4,5)P₃,⁴³ and PI(4,5)P₂.⁴⁴ SopB is required for the S. enterica phagosome maturation arrest, as knockout strains lacking SopB are more efficiently delivered to phagolysosomes.⁴⁴

M. tuberculosis

Phagosomes containing viable M. tuberculosis can be devoid of PI(3)P, a feature likely caused by the M. tuberculosis secreted PI(3)P phosphatase SapM (secreted acid phosphatase of M. tuberculosis).⁴⁵ Phagosomes containing SapM-deficient M. tuberculosis acidify⁴⁶ and fuse with lysosomes,⁴⁷ yet it has not been tested when and how much PI(3)P they acquire.

Another M. tuberculosis PIP phosphatase, MptpB (M. tuberculosis protein tyrosine phosphatase), dephosphorylates PI(3)P, PI(4)P, PI(5)P, and PI(3,5)P₂ in vitro.⁴⁸ Mutant strains lacking MptpB are killed by activated macrophages in guinea pigs.⁴⁹ Possibly, MptpB deletion mutants are more readily delivered to and killed within phagolysosomes which, however, remains to be tested. Moreover, it is unclear, whether MptpB acts by dephosphorylating PIPs and/or proteins in vivo.

L. pneumophila

The Legionella effector protein SidP (substrate of Icm/Dot transporter P) secreted through a type IV secretion system dephosphorylates PI(3)P and PI(3,5)P₂,⁵⁰ whereas SidF is a secreted PI(3,4)P₂ and PI(3,4,5)P₃ phosphatase.⁵¹ Knock-out strains lacking either of these effector proteins have not been tested for interference with phagosome maturation.

The above observations point to an essential role of PIPs in phagosome maturation. To truly understand how manipulation of PIPs can contribute to altered trafficking of phagosomes, it is necessary to define which PIPs are required for each step of the default maturation of phagosomes into phagolysosomes.

Analysis of PIP involvement in phagosome maturation using intact cells or purified compartments

Whether and which PIPs are required for phagolysosome formation can be determined using a combination of techniques to track the progression of phagosome maturation, to specifically visualize PIP isomers, and to manipulate the PIP composition of phagosomes.

As detailed below, in whole cells, the progression of phagosome maturation can be analyzed by visualizing marker proteins or lipids that specify early phagosomes, late phagosomes, or phagolysosomes, and phagosome PIPs can be detected by ectopically expressed fluorescent protein- or epitope-tagged lipid-binding domains. The impact of PIPs on phagosome maturation can be assessed by overexpression of PIP-binding domains to sequester defined PIP species or by manipulating the PIP composition of phagosomes using inhibition, silencing, depletion, and/or overexpression of PIP-modifying enzymes. Moreover, polyamine carrier-complexed exogenous PIPs or membrane-permeable PIP analogs can be incorporated into subcellular membranes, including phagosomes. Alternatively, sub-reactions of phagosome maturation (e.g., phagosome-lysosome fusion) can be reconstituted in vitro with purified compartments. In such cell-free assays, phagosome/endosome PIPs can be detected by PIP-binding domains or antibodies, TLC, HPLC, and/or mass spectrometry and PIP-sequestering protein domains or PIP-modifying enzymes can be used to identify PIPs relevant to the sub-reaction of phagosome maturation studied.

Analysis of PIP requirements of phagosome maturation in whole cells

As they mature, phagosomes pick up and lose endocytic marker molecules following a characteristic temporal pattern. Accordingly, different-aged phagosomes vary in marker molecule composition: early phagosomes contain Rab5, the transferrin receptor (TfR), and syntaxin 13 (Stx13); late phagosomes lack early endocytic proteins and possess Rab7, lysosomal hydrolases (e.g., cathepsins), and LAMPs (lysosome-associated membrane proteins).^1,3 The composition of phagolysosomes is very similar to that of late phagosomes. Differentiation between late phagosomes and phagolysosomes is possible in that the latter acquire fluid phase tracers (e.g., fluorochrome-conjugated dextrans) preloaded into lysosomes,³ although even after very long chase periods, some of the tracer will still be in late endosomes.⁵² Visualization of endocytic marker molecules on phagosomes at different times post phagocytosis allows to track the progression of phagosome maturation and to reveal altered maturation of phagosomes in experimentally manipulated or pathogen-infected cells.

The use of lipid-binding proteins to visualize PIPs on maturing phagosomes in intact cells

An important step toward the understanding of how PIPs govern phagosome maturation was to determine which PIPs occur on phagosomes at defined maturation stages. To this end, numerous studies have analyzed association of overexpressed fluorescent protein-tagged PIP-binding domains with nascent and/or maturing phagosomes. This approach has provided a detailed picture of the PIP dynamics at sites of phagocytosis⁴⁰ and on early phagosomes, yet it only occasionally detected PIPs on late phagocytic compartments.^53,54

Notably, overexpression of PIP-binding protein domains can compete with membrane recruitment of the relevant, authentic PIP effectors and, hence, inhibit PIP-dependent cellular processes.^27,55 For instance, overexpression of PI(3)P-binding probes (i.e., 2xFYVE domain of EEA1 or PX domain of p40^phox) to visualize PI(3)P blocks phagosome maturation at an early stage,¹⁵ making this approach unsuitable to analyze the PI(3)P content of late phagosomes or phagolysosomes.

To circumvent alterations of phagosome maturation due to ectopic expression of lipid-binding probes, the experimenter can use epitope-tagged and/or fluorochrome-conjugated PIP probes or PIP-specific antibodies with fixed and permeabilized, untransfected cells.^27,55 For example, Alexa633-conjugated 2xFYVE domain of Hrs has been used to reveal the presence of PI(3)P on latex bead phagosomes (LBPs) and its absence from M. tuberculosis phagosomes.³² However useful for solving certain questions, this approach fails to detect PIPs which were already complexed with downstream effector proteins.²⁷ In sum, combining low expression levels of genetically encoded fluorescent PIP sensors and high sensitivity imaging techniques might be the key to detection of PIPs on maturing phagosomes without affecting phagosome maturation and to visualize PIPs on late phagocytic compartments, too.

Recombinant PIP probes or antibodies for the detection of all PIP isomers are available. Importantly, however, the suitability of ML1Nx2 (2 copies of residues 1–68 of TRPML1) as one of a very few selective PI(3,5)P₂ probes is disputed.^26,56 Moreover, specific PI(5)P-binding protein domains have not yet been used to visualize this PIP in cells.

Presence of a given PIP in phagosomes suggests that it may be required for the progression of phagosome maturation, yet it does not provide proof. Hence, to identify which PIPs are actually relevant to phagosome maturation, PIPs or the enzymes involved in their turnover need to be manipulated, as detailed below.

The use of lipid-binding proteins to sequester defined PIP isomers in intact cells

As discussed above, competitive inhibition of phagosome maturation by ectopically expressed PIP-binding domains can preclude visualization of PIPs on late phagosomes or phagolysosomes. However, it can also be exploited to identify PIPs relevant to phagosome maturation. For instance, sequestration of PI(3)P by overexpression of a high-avidity PI(3)P probe (5 copies of FYVE domain of Hrs [hepatocyte growth factor regulated tyrosine kinase substrate]) blocked actin polymerization on early phagosomes and concomitantly early-to-late phagosome transition.⁵⁷

Since specific binding probes are available for each PIP isomer, the sequestration approach can be used to assign roles in phagosome maturation to the various PIPs, with the following limitations: (i) Phagocytosis depends on PI(4,5)P₂ which is generated from PI(4)P by phosphatidylinositol 4-phosphate 5-kinase Iα. Sequestration of PI(4)P or PI(4,5)P₂ will delay phagocytosis,⁵⁸ which could be mistaken for inhibition of phagosome maturation. This problem could be circumvented using live cell imaging and analysis of individual phagosomes after completion of phagocytosis. (ii) The various subreactions of phagosome maturation are interdependent. Thus, if phagosome maturation required a given PIP in more than one step, the sequestration approach would block the first step depending on this PIP, thereby obscuring the impact of PIP sequestration on the following step(s).

Inhibition, silencing, or depletion of PIP-modifying enzymes in living cells

Inhibitors of PIP-modifying enzymes

Inhibitors to specifically block the formation and/or consumption of a given PIP by PIP kinases or PIP phosphatases are available and some of these agents have already been used to analyze the interplay of PIP metabolism and phagosome maturation:

Pharmacological inhibitors Phosphatidylinositol 3-kinase (PI3K) inhibitors

Mammals possess 3 classes of PI3K which differ in structure, regulation, and substrate preference and generate PI(3)P, PI(3,4)P₂, or PI(3,4,5)P₃ by phosphorylation of the D3-hydroxyl group of PI, PI(4)P, or PI(4,5)P₂.⁵⁹

The panspecific PI3K inhibitor wortmannin (WM) has been widely used to analyze the contribution of PI3Ks to phagosome maturation. Phagosomes in WM-treated cells get stuck at an early maturation stage; they contain less PI(3)P and EEA1, do not release Rab5, and do not acquire Rab7, LAMP1, or a fluid phase tracer preloaded into lysosomes.^4,60-62 Microinjection into phagocytes of an antibody which specifically inhibits class III PI3K Vps34 ⁶³ also decreases contents of phagosomes in PI(3)P, EEA1, and LAMP1.^61,62 Thus, Vps34 is the major target of WM here, although another WM-sensitive PI3K, i.e. class IA PI3K p110α, is also involved in phagosome maturation.⁶⁴ Recently, more isoform-specific PI3K inhibitors have been identified, which may, in the future become useful in phagosome research. These include inhibitors of class I PI3K isoforms (e.g., YM024 (p110α), TGX221 (p110β), and AS252424 (p110δ))³⁹ and of class III PI3K Vps34 (e.g., PIK-III,⁶⁵ SAR405,⁶⁶ and Vps34-IN1 ⁶⁷).

Phosphatidylinositol 4-kinase (PI4K) inhibitors

Mammals possess 4 different PI4Ks, i.e., PI4KIIα, PI4KIIβ, PI4KIIIα, and PI4KIIIβ. Isoform-specific inhibitors of class II PI4Ks are not available. Class III PI4Ks, by contrast, are sensitive to A1 (PI4KIIIα⁶⁸) or Pik-93 (PI4KIIIβ⁶⁹). These inhibitors, however, also target PI3Ks, limiting their use in analysis of phagosome maturation which requires both class IA and class III PI3K activity.

Phosphatidylinositol 5-kinase (PI5K) inhibitors

The pharmacological inhibitors of the phosphatidylinositol 3-phosphate 5-kinase (PI3,5K) PikFYVE, namely MF-4, apilimod, and YM201636, block phagosome maturation before the late phagosome/phagolysosome stage, suggesting that PikFYVE and its lipid product PI(3,5)P₂ regulate phagosome maturation.⁷⁰ As PikFYVE also generates PI(5)P from PI,⁷¹ it remains to be tested whether phagosome maturation requires PI(5)P, PI(3,5)P₂, or the both of these lipids.

Further PIK inhibitors and PIP phosphatase inhibitors

Type II phosphatidylinositol 5-phosphate 4-kinases (PI5,4KIIs) generate PI(4,5)P₂ from PI(5)P. PI5,4KII isoforms β and γ are selectively blocked by SAR088⁷² and NIH-12848,⁷³ respectively. Selective inhibitors of phosphatidylinositol 4-phosphate 5-kinases (PI4,5Ks) have not yet been identified.

Pharmacological inhibitors of PIP phosphatases include VO-OHpic inhibiting PTEN (phosphatase and tensin homolog),⁷⁴ YU142670 inhibiting OCRL (oculocerebrorenal syndrome of Lowe) and Inpp5b (inositol polyphosphate 5-phosphatase),⁷⁵ and AS1949490 inhibiting SHIP2 (SH2 domain containing inositol 5-phosphatase 2).⁷⁶ Although PTEN,⁷⁷ OCRL, and Inpp5b⁷⁸ manipulate the PIP composition of phagosomes, the corresponding inhibitors have not yet been tested for interference with phagosome maturation.

PIK-inhibiting antibodies

Inhibitory antibodies against PI3Ks Vps34 and p110α,⁶³ and class II PI4Ks⁷⁹ have been generated. Class IA PI3K p110α- or class II PI4K-inhibiting antibodies have not been tested for interference with phagosome maturation in whole cells. By contrast, introduction of a Vps34-inhibiting antibody into macrophages blocks phagosome maturation at the early phagosome stage.^61,62 A major obstacle to the in vivo use of such antibodies is that immunoglobulins do not permeate membranes and hence need to be introduced into cells by microinjection or proteofection.

Silencing or depletion PIP-modifying enzymes

To assign certain PIPs a role in phagosome maturation, some studies have used siRNA-mediated reduction of expression of PIP-modifying enzymes and revealed that PI3,5K PikFYVE and phosphatidylinositol 3-phosphatase PTEN remove PI(3)P from early phagosomes⁷⁷ and that phagolysosome formation requires class IA PI3K p110α ⁶⁴ and PikFYVE.⁷⁰ Moreover, in macrophages from mice lacking the PI(3,4,5)P₃ 5-phosphatase SHIP1, phagosomes were decreased in PI(3,4)P₂ and in NADPH oxidase activity.⁸⁰

A related approach to test the impact of a PIP-modifying enzyme on a given cellular process is to ectopically express enzymatically inactive versions of the respective enzyme. These mutated enzymes often act in a dominant-negative fashion through binding to PI or PIPs without being able to perform the proper function and, hence, essentially function like isolated PI or PIP-binding domains (s. above). Their overexpression often reproduces phenotypes seen with expression knock-down or pharmacological inhibition of the corresponding enzymes.

Inhibition or siRNA-mediated knock down of PIP effector proteins in whole cells

PIPs usually are ‘white collar’ compounds which recruit downstream effector proteins to perform the actual job. The identification of PIP effectors is therefore an important step toward the understanding of how PIPs govern a cellular process. PIP-binding proteins which are recruited to maturing phagosomes are good candidate regulators of phagolysosome biogenesis. Putative phagosome PIP effectors can be tested for involvement in phagosome maturation by selective inhibitors –if available– or by siRNA-mediated expression silencing. For instance, microinjection into phagocytes of antibodies against the PI(3)P effector EEA1 blocks phagosome maturation,⁶² as does expression knock down of PI(3)P effectors Hrs,¹⁵ SNX1, SNX6, SNX9,¹⁶ FYCO-1 (FYVE and coiled-coil domain containing 1)⁸¹ or of the PI(3,5)P₂ effector TRPML1 (transient receptor potential cation channel, mucolipin subfamily, member 1).¹⁹

Acute manipulation of PIPs in living cells

Ectopic expression or silencing of PIP-modifying enzymes in (phagocytic) cells takes days. Inhibitory antibodies against PIP kinases or PIP phosphatases act more quickly, yet still need to be introduced into cells hours before phagocytosis.^61,63

Pharmacological inhibitors allow for more acute manipulations of cellular PIP metabolism; e.g., PI3K inhibitor WM blocks phagosome maturation even if administered after completion of phagocytosis.^4,57,62 Addition of pharmacological inhibitors at different times post phagocytosis hence can be used to analyze late subreactions of phagosome maturation detached from preceding maturation events. Using this approach, we showed that late phagosome-to-lysosome fusion in vivo is WM-sensitive and PI3K-dependent.⁴

Recently, a technique has been developed to acutely deplete a defined PIP from a given subcellular compartment in living cells. This technique relies on the rapamycin-induced heterodimerization of FKBP12 and the FRB (FKBP12-rapamycin binding) domain of mTOR (mechanistic target of rapamycin). A PIP-modifying enzyme of interest is fused to FRB domain of mTOR and a membrane receptor of choice to FKBP12. Upon coexpression of the resulting fusion proteins in cells, addition of rapamycin to the culture medium makes the PIP-modifying enzyme bind to and convert PIPs in vicinity of the corresponding membrane receptor. Basically, this heterodimerization approach is suitable to increase or reduce the amount of a PIP in any defined subcellular compartment (e.g., phagosomes, endosomes, Golgi) within minutes. Yet, importantly, membrane receptor and PIP-modifying enzyme need to be carefully chosen: Ideally, the membrane receptor is a cytosol-exposed transmembrane protein unique to the compartment to be analyzed and the PIP-modifying enzyme targets just one of the various PIP isomers.

The above technique has already been used to target PIP-modifying enzymes to phagocytic or endocytic compartments: Bohdanowicz and coworkers targeted a phosphatidylinositol 4-phosphate 5-kinase to nascent/early phagosomes, leading to an accumulation of PI(4,5)P₂ in these compartments.⁵⁷ Hammond et al. targeted PI(4)P phosphatase Sac1p to late endocytic, Rab7-positive compartments which resulted in a decrease of late endosomes in PI(4)P.³⁵

To study PIP involvement in phagosome maturation, one could use stage-specific marker proteins of early and late endosomes/phagosomes as membrane receptors for PIP-modifying enzymes. However, as marker molecules unique to lysosomes have not yet been identified,³ there is no membrane receptor available to specifically deliver PIP-modifying enzymes to (phago)lysosomes. Hence, the impact of PIPs on phagosome-lysosome fusion is difficult to analyze by the above method.

Incorporation of exogenous PIPs into subcellular compartment membranes of live cells

Aside the aforementioned approaches to manipulate endogenous PIPs, methods to incorporate exogenically added PIPs into subcellular compartment membranes of live cells have been developed. These methods rely on either membrane-permeable PIP analogs^39,82 or polyamine carriers that complex PIPs and guide them through membranes.⁸³ In both cases, the negative charges of the PIP headgroup are masked either by chemical modification or by binding of a suitable, positively charged polyamine.

Although PIPs are unselectively incorporated into subcellular compartment membranes^39,82 using these methods, addition to cells of a membrane-permeable PI(3)P analog specifically stimulated homotypic early endosome fusion,⁸⁴ a PI(3)P-dependent process.⁸⁵ Moreover, intracellular delivery of PI(4)P or PI(5)P by polyamine carriers recently assigned these PIPs roles in autophagosome-lysosome fusion⁸⁶ and autophagosome formation,⁸⁷ respectively.

Introduction of exogenous PIPs into live cells, for instance, could be useful to clarify whether the phagosome maturation block caused by WM^60,64 is due to decreased levels of PI(3)P, PI(3,4)P₂, and/or PI(3,4,5)P₃. To this end, it could be tested whether intracellular delivery of the above D3-PIPs alone or in combinations can revert inhibition of phagolysosome formation in phagocytes treated with WM.

Cell-free analysis of PIP requirements of phagosome maturation

The cell-free reconstitution of membrane fusion pathways has proven to be well-suited to identify fusion-relevant factors, as masterfully exemplified by the purification of N-ethylmaleimide-sensitive fusion factor (NSF) by Block and coworkers in 1988.⁸⁸ Moreover, it can be used to order fusion sub-reactions (i.e., priming, tethering, docking, [hemi]fusion) and has led to identification of the function of NSF as a SNARE chaperone⁸⁹ and of SNAREs as fusion catalysts.⁹⁰ Cell-free fusion assays further are compatible with addition of membrane-impermeable inhibitory agents, such as inhibitory antibodies or recombinant proteins, or with inhibitors toxic to the cell.

Phagosome maturation comprises a number of hierarchically ordered sub-reactions which impedes analysis of this process in intact cells: If a factor were required for early and late subreactions, then its inhibition would block phagosome maturation early and obscure the effects of such treatment on later stages. This issue can be circumvented by reconstituting phagosome maturation sub-reactions in cell-free systems. To this end, phagosomes and endosomes are purified at different times post phagocytosis or endocytosis yielding phagocytic and endocytic compartments of different maturation stages. These compartments are mixed in a test tube with cytosolic proteins, an ATP-regenerating system, and ions. Incubation at physiological temperature leads to membrane fusion which can be quantified by various methods: Fusion assays between phagosomes and endosomes are based either on the formation of an avidin-biotin HRP (horseradish peroxidase) complex, on dequenching of a fluorescent lipid analog introduced into lysosomes, or on colocalization of phagosomes with a fluorescent tracer preloaded into endocytic compartments (for a review see ref. 91).

In cell-free fusion experiments, the compartments to be fused are incubated under conditions designed to mimick the cytoplasmic situation. Nevertheless, not all aspects of phagosome maturation are readily reconstructed in vitro: For instance microtubules are required for phagolysosome formation in whole cells,⁹² yet dispensable for reconstituted late phagosome-lysosome fusion.² Hence, observations made with cell-free fusion assays always need to be validated, as good as possible, in experiments using intact cells. But, of course, experiments with complete, live cells have their potential drawbacks, too. E.g., knock down of expression of an important gene may result in uncontrolled additional changes in the same cell.

PIP involvement in vitro is studied by adding PIP-sequestering protein domains to fusion reactions. If a given PIP were required for fusion, sequestration of this PIP would inhibit the reconstituted reaction. This approach has been used for various reconstituted membrane fusion reactions and has identified PI(3)P, PI(4)P, and PI(4,5)P₂ as required for yeast vacuole fusion,^93,94 PI(4)P as required for COPII vesicle-Golgi fusion,⁹⁵ and PI(3)P as required for homotypic early endosome fusion.^96,97 Importantly, PIP-binding domains specific for each of the various PIP isomers have been identified, so that each PIP can be analyzed for involvement in a given fusion reaction.

Additional to the experimental approach of masking PIPs by specific protein domains, dephosphorylating them can also reveal their requirement in membrane fusion. For instance, reconstituted fusion between yeast vacuoles and between phagosomes and lysosomes depend on PI(3)P and hence are blocked by addition of recombinant PI(3)P phosphatase MTM1 (myotubularin).^4,93

We recently used this approach to identify PIPs relevant for phagosome maturation and showed that PI(3)P is required for fusion of early phagosomes with early endosomes and of late phagosomes with lysosomes, whereas PI(4)P is selectively required for late phagosome-lysosome fusion⁴ (Fig. 1).

Figure 1.

Regulation of phagolysosome formation by phosphatidylinositol 3-phosphate and phosphatidylinositol 4-phosphate. During phagocytosis, phagocytes ingest large particles (e.g. microorganisms) into plasma membrane-derived phagosomes. These mature into microbicidal and degradative phagolysosomes (‘PLYS’), leading to killing and destruction of the enclosed cargo. Solutes and small particles (< 400 nm in diameter) are taken up by endocytosis. The resulting endosomes deliver their cargo to lysosomes (‘LYS’) where it is degraded. Three different compartments have been defined for both, the phagocytic and the endocytic pathway: Early phagosomes/endosomes (‘EP’/‘EE’), late phagosomes/endosomes (‘LP’/‘LE’), and phagolysosomes/lysosomes. Note that the definition of 3 different phagocytic or endocytic compartments substantially simplifies the diversity of organelles along the phagocytic and endocytic pathway. As phagosomes mature, they sequentially fuse with and acquire the characteristics of early endosomes, late endosomes, and lysosomes. Blue arrows mark the progression of phagosome maturation. The different phagosome-endo(lyso)some fusion events are indicated by black, double-sided arrows. Dependence of the reconstituted phagosome-endo(lyso)some fusion on PI(3)P (‘3’) or PI(4)P (‘4’), as judged by its sensitivity to PI(3)P- or PI(4)P-sequestering protein domains, is indicated: ‘-’, no inhibition; ‘+’, >25% inhibition; ‘++’, >50% inhibition; ‘+++’, >75% inhibition. In summary, PI(3)P regulates phagosome maturation at early and late stages, whereas PI(4)P is selectively required late in the pathway.

The likely role of PI(3)P in early phagosome-early endosome fusion is to recruit and/or anchor EEA1 to early endocytic and phagocytic compartments, a tethering factor which is required for homotypic early endosome fusion⁹⁷ and, presumably, early phagosome-early endosome fusion.³ How PI(3)P governs phagosome-lysosome fusion is unclear, yet it might serve to recruit fusion-relevant proteins to late phagosomes/endosomes, such as the “priming” ATPase NSF,⁹⁸ the “tethering” factors, HOPS⁹⁹ or FYCO-1,¹⁰⁰ and/or the “docking” late endocytic R-SNARE Vamp8.¹⁰¹

As with PI(3)P, PI(4)P might serve to recruit fusion factors to late phagosomes/endosomes, such as NSF⁹⁸ and HOPS.⁹⁹ The recent observation that PI(4)P-generating PI4KIIα interacts with the late endocytic R-SNARE Vamp7 which had been implicated in phagosome-lysosome fusion earlier,² supports the hypothesis that PI4Ks, PI4KIIIβ and PI4KIIα, and their common lipid product PI(4)P are required for late phagosome/endosome maturation.^102,103

Analysis of PIP kinase activities associated with phagosomes

We recently identified the kinases responsible for the formation of PI(3)P and PI(4)P in phagolysosomes. To this end, we incubated purified latex bead phagolysosomes under fusion assay conditions and visualized phagosomal PI(3)P or PI(4)P using 2xFYVE domain and a PI(4)P-specific antibody, respectively. Addition of inhibitory antibodies against class III PI3K Vps34 or class II PI4Ks strongly decreased levels of PI(3)P and PI(4)P in phagosomes.⁴ This approach would hardly have been possible with intact cells, as the use of inhibitory antibodies requires introduction of these molecules into cells which is difficult to achieve. Moreover, in the case of Vps34 inhibition, phagosome maturation would have been blocked early, impeding analysis of PI3K activities associated with phagolysosomes.^60,61

In general, this assay is applicable to each purified organelle, as exemplified in our recent publication for different-aged latex bead phagosomes and paramagnetically labeled early endosomes, late endosomes, or lysosomes.⁴ Moreover, the method can be adapted to analyze activities of other PIP-modifying enzymes, because specific probes are available for each PIP isomer. For instance, using the PH domain of PLCδ1 (phospholipase C δ) as a probe for PI(4,5)P₂, we observed that during in vitro incubation phagolysosome PI(4)P is constantly converted to PI(4,5)P₂⁴ as described previously.¹⁰⁴

Outlook

Fifteen years ago, Vieira and coworkers observed that class III PI3K Vps34 and its lipid product PI(3)P are required for phagosome maturation.⁶¹ Since then, it has been shown for all PIP isomers, except for PI(5)P and PI(3,5)P₂, that they regulate the development of newly formed phagosomes into microbicidal phagolysosomes (Table 1). Moreover, we now know that some intracellular pathogens possess PIP-modifying effector proteins which, upon introduction into host cells, manipulate the PIP composition of pathogen-containing phagosomes^41,42 and help to inhibit their fusion with microbicidal lysosomes. Yet, to truly understand how manipulation of PIPs can contribute to altered trafficking of phagosomes, it is necessary to systematically identify the PIPs required for each step of the default maturation of phagosomes into phagolysosomes. This can be done using cell-free reconstitution of fusion between phagosomes and endosomes of different maturation stages and PIP-sequestering protein domains, an approach which recently identified PI(3)P as needed for fusion of phagosomes with early endosomes or lysosomes and PI(4)P as selectively required for phagosome-lysosome fusion.⁴ Briefly, comprehensive mapping of the PIP requirements along the phagosome maturation sequence, as exemplified for PI(3)P and PI(4)P in Figure 1 is an important task for the future.

Since PIPs use effector proteins as mediators of their downstream functions, the identification of PIP effectors is a crucial step toward the understanding of how PIPs govern a cellular process. Phagosomal/endosomal PIP effector proteins can be purified from detergent lysates of isolated phagosomes/endosomes using PIP-coated beads or PIP-containing liposomes. After mass spectrometric identification, putative PIP effectors can be tested for involvement in phagolysosome formation using the various approaches described in this article.

Once PIPs and the corresponding effectors relevant to a given step of phagosome maturation have been identified, cell-free fusion assays can be used to determine whether a PIP or a PIP effector is required for the priming, tethering, docking, and/or (hemi)fusion sub-reaction of phagosome-endosome fusion. Such dissection of fusion sub-reactions has especially been done for reconstituted homotypic yeast vacuole fusion,¹⁰⁵ yet, presumably is readily adapted to also study phagosome-endosome fusion.

Reconstituted fusion between different-aged phagosomes and endosomes will allow to assign bacterial PIP-modifying effector proteins to a given sub-reaction of phagosome maturation. This will enrich our understanding of how the phagosome's fate is reprogrammed by pathogens: Recently, it has been reported that Legionella effector LegC3 and Vibrio parahaemolyticus effector VopQ block homotypic yeast vacuole fusion.^106,107 These observations underline the wide range of eukaryotic species against which pathogen effectors can act, likely because they are usually targeted to central regulatory components which are often highly conserved. However, as yeast is not a natural host of Legionella nor of Vibrio, inhibitory actions of these effectors need be also tested with purified compartments from mammalian cells. Importantly, using our fusion assay setup, we have reproduced inhibition of phagosome-lysosome fusion seen with S. enterica-containing phagosomes in intact cells.² Hence, cell-free fusion analysis can be used to analyze both, interference with fusion by pathogen factors and identification of factors that force pathogen phagosomes to fuse with lysosomes, e.g., after macrophage activation.

Given the currently big interest into PIPs and into how they regulate cellular processes, we will likely soon have a detailed map of how PIPs govern regular phagolysosome formation. Such map will help to understand how pathogen infection and other pathological events alter host cell PIP metabolism and will offer new approaches to disease intervention.

Funding Statement

We thank the German Science Foundation (Deutsche Forschungsgemeinschaft) for funding our research through collaborative research center SFB645/C2 and through the priority program SPP1580.

Abbreviations

ANTH

AP180 N-terminal homology

C2

conserved region-2 of protein kinase C

COPII

coat protein complex II

EEA1

early endosome antigen 1

ENTH

epsin N-terminal homology

ESCRT

endosomal sorting complex required for transport

FERM

Protein 4.1, Ezrin, Radixin Moesin

FRB

FKBP12-rapamycin binding domain of mTOR

FYCO-1

FYVE and coiled-coil domain containing 1

FYVE

Fab1, YOTB, Vac1, EEA1

GFP

green fluorescent protein

Golph3

golgi phosphoprotein 3

GRAM

glycosyltransferases, Rab-like GTPase activators and myotubularins

HOPS

homotypic fusion and vacuole protein sorting

HPLC

high performance liquid chromatography

HRP

horseradish peroxidase

Hrs

hepatocyte growth factor regulated tyrosine kinase substrate

Inpp5b

inositol polyphosphate 5-phosphatase

LAMPs

lysosome-associated membrane proteins

LBP

latex bead phagosome

MptpB

M. tuberculosis protein tyrosine phosphatase

MTM1

myotubularin

mTOR

mechanistic target of rapamycin

NSF

N-ethylmaleimide-sensitive fusion factor

OCRL

oculocerebrorenal syndrome of Lowe

PDZ

postsynaptic density 95, disk large, zonula occludens

PH

pleckstrin homology

PHD

plant homeodomain

PI(3)P

phosphatidylinositol 3-phosphate

PI(3,4,5)P₃

phosphatidylinositol 3,4,5-trisphosphate

PI(3,4)P₂

phosphatidylinositol 3,4-bisphosphate

PI(3,5)P₂

phosphatidylinositol 3,5-bisphosphate

PI(4)P

phosphatidylinositol 4-phosphate

PI(4,5)P₂

phosphatidylinositol 4,5-bisphosphate

PI(5)P

phosphatidylinositol 5-phosphate

PI

phosphatidylinositol

PI3K

phosphatidylinositol 3-kinase

PI4,5K

phosphatidylinositol 4-phosphate 5-kinase

PI4K

phosphatidylinositol 4-kinase

PI5,4KII

type II phosphatidylinositol 5-phosphate 4-kinase

PI5K

phosphatidylinositol 5-kinase

PIK

phosphoinositide kinase

PIP

phosphoinositide

PLCδ1

phospholipase Cδ1

PTB

phosphotyrosine binding

PTEN

phosphatase and tensin homolog

PX

phox homology

Rab

Ras-like protein fom rat brain

RNS

reactive nitrogen species

ROS

reactive oxygen species

SAND1/Mon1-Ccz1

SAND1, SAND endocytosis protein family 1

Mon1

monensin sensitivity 1

Ccz1

calcium caffeine zinc sensitivity 1

SapM

secreted acid phosphatase of M. tuberculosis

SHIP1

SH2 domain containing inositol 5-phosphatase 1

SHIP2

SH2 domain containing inositol 5-phosphatase 2

SidF

substrate of Icm/Dot transporter F

SidP

substrate of Icm/Dot transporter P

SNARE

soluble NSF attachment protein receptor

SNXs

sorting nexins

SopB

Salmonella outer protein B

Stx13

syntaxin 13

TfR

Transferrin receptor

TLC

thin layer chromatography

TRPML1

transient receptor potential cation channel, mucolipin subfamily, member 1

vATPase

vacuolar ATPase

Vps34

vacuolar protein sorting 34

WM

wortmannin

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.